BlackRock increases its stake in WuXi Biologics and reduces its stake in Meituan
According to information from the Hong Kong Stock Exchange, BlackRock's shareholding in WuXi Biologics increased from 4.99% to 5.47% on August 25; its shareholding in Meituan-W decreased from 6.23% to 5.99% on August 25
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments